Intralesional anti-PD1 treatment in patients with metastatic melanoma: The pilot study.

被引:6
|
作者
Samoylenko, Igor
Korotkova, Olga V.
Zabotina, Tatiana
Demidov, Lev V.
机构
[1] NN Blokhin Russian Canc Res Ctr, Moscow, Russia
[2] Russian Acad Med Sci, NN Blokhin Canc Res Ctr, Moscow, Russia
关键词
D O I
10.1200/JCO.2018.36.5_suppl.188
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
188
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanoma
    Simeone, Ester
    Grimaldi, Antonio M.
    Ascierto, Paolo A.
    [J]. MELANOMA MANAGEMENT, 2015, 2 (01) : 41 - 50
  • [2] Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands
    van der Kooij, M. K.
    Joosse, A.
    Speetjens, F. M.
    Hospers, G. A. P.
    Bisschop, C.
    de Groot, J. W. B.
    Koornstra, R.
    Blank, C. U.
    Kapiteijn, E.
    [J]. ACTA ONCOLOGICA, 2017, 56 (01) : 101 - 103
  • [3] Toxicity and Survival for Metastatic Melanoma Patients Treated With Anti-PD1 Therapy and Radiation Treatment
    Mowery, Y. M.
    Patel, K.
    Olson, A. C.
    Khan, M. K.
    Salama, J. K.
    Salama, A. K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S158 - S159
  • [4] Anti-PD1 antibodies in late elderly advanced melanoma patients: A retrospective multicentre study.
    De Rosa, Francesco
    Ridolfi, Laura
    Tanda, Enrica Teresa
    Marra, Elena
    Pigozzo, Jacopo
    Marconcini, Riccardo
    Guida, Michele
    Gallizzi, Giulia
    Occelli, Marcella
    Pala, Laura
    Gambale, Elisabetta
    Bersanelli, Melissa
    Conca, Raffaele
    Cortellini, Alessio
    Morgese, Francesca
    Zoratto, Federica
    Stucci, Luigia Stefania
    Strippoli, Sabino
    Petracci, Elisabetta
    Guidoboni, Massimo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] ANTI-PD1 THERAPY IN PATIENTS WITH METASTATIC MELANOMA: A SINGLE CENTRE EXPERIENCE
    Nguyen, B.
    Robinson, E.
    Arora, A.
    Sayed, A.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 65 - 65
  • [6] "Interchangeability" of anti-PD1 antibodies in patients (pts) with metastatic melanoma (mM)
    Kravchuk, Darya
    Fedyanin, Mikhail
    Rays, Anastasia
    Moiseenko, Fedor Vladimirovich
    Ivanilov, Kirill
    Popov, Vladimir
    Glazkova, Elena
    Chubenko, Viacheslav
    Levchenko, Evgeny
    Volkov, Nikita
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Predicting the response to anti-PD1 therapy in metastatic melanoma
    Heinzerling, Lucie
    Kirchberger, Michael Constantin
    Walter, Lisa
    Schuler, Gerold
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S576 - S579
  • [8] Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study
    Ridolfi, Laura
    De Rosa, Francesco
    Petracci, Elisabetta
    Tanda, Enrica Teresa
    Marra, Elena
    Pigozzo, Jacopo
    Marconcini, Riccardo
    Guida, Michele
    Cappellini, Gian Carlo Antonini
    Gallizzi, Giulia
    Occelli, Marcella
    Pala, Laura
    Gambale, Elisabetta
    Bersanelli, Melissa
    Galdo, Giovanna
    Cortellini, Alessio
    Morgese, Francesca
    Zoratto, Federica
    Stucci, Luigia Stefania
    Strippoli, Sabino
    Guidoboni, Massimo
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (03) : 515 - 522
  • [9] Anti-PD1 role in treatment of cutaneous melanoma
    Mateus, Christine
    Libenciuc, Cristina
    Robert, Caroline
    [J]. BULLETIN DU CANCER, 2016, 103 (06) : S4 - S11
  • [10] Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy
    Amato, Carol M.
    Hintzsche, Jennifer D.
    Wells, Keith
    Applegate, Allison
    Gorden, Nicholas T.
    Vorwald, Victoria M.
    Tobin, Richard P.
    Nassar, Kelsey
    Shellman, Yiqun G.
    Kim, Jihye
    Medina, Theresa M.
    Rioth, Matthew
    Lewis, Karl D.
    McCarter, Martin D.
    Gonzalez, Rene
    Tan, Aik-Choon
    Robinson, William A.
    [J]. CANCERS, 2020, 12 (07) : 1 - 15